Review of French Cases of Glutathione Synthetase Deficiency
NCT02830867 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-01-10
Summary
The glutathione synthetase deficiency, inborn error of metabolism of autosomal recessive inheritance, is a rare disease (70 patients described in the world). The outcome of these patients and potential complications of this disease are not, to date, yet all known and described.
Conditions
- The Glutathione Synthetase Deficiency
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2018-10-31
- Completion
- 2018-10-31
Countries
- France
Study Locations
More Related Trials
-
L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
NCT00125788 ·Status: COMPLETED ·Phase: PHASE2
-
Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease
NCT04983654 ·Status: COMPLETED ·Phase: NA
-
Prognostic Factors of Acute Splenic Sequestration
NCT01207037 ·Status: COMPLETED ·Phase: NA
-
Inflammation, Platelets and Sickle Cell Disease
NCT05646888 ·Status: ACTIVE_NOT_RECRUITING
-
Full Assessment of Clinical Transfusion Support
NCT07094646 ·Status: COMPLETED
-
Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes
NCT02855957 ·Status: COMPLETED ·Phase: NA
-
Quality of Care of Children With Sickle Cell Disease (SCD) Screened at Birth in France
NCT03119922 ·Status: COMPLETED
-
Vascular Function Intervention Trial in Sickle Cell Disease
NCT01718054 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
NCT01556360 ·Status: COMPLETED
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
NCT01179217 ·Status: COMPLETED ·Phase: PHASE3
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA
-
Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies
NCT03837119 ·Status: COMPLETED
-
Perceptions of Thalassemia Major in Singapore: An Exploratory Study of Stigma
NCT01129076 ·Status: COMPLETED
-
Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease
NCT01987908 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
NCT00981370 ·Status: TERMINATED ·Phase: PHASE3
-
Vitamin D and Bisphosphonates in the Treatment of Sickle Cell Disease
NCT02972138 ·Status: COMPLETED
-
Genetic Factors Affecting the Severity of Beta Thalassemia
NCT00159042 ·Status: COMPLETED
-
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837 ·Status: COMPLETED
-
Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell Disorder
NCT06251843 ·Status: NOT_YET_RECRUITING
-
Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation
NCT06619093 ·Status: NOT_YET_RECRUITING
-
Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound
NCT02829580 ·Status: COMPLETED ·Phase: NA
-
Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
NCT01810965 ·Status: COMPLETED ·Phase: NA
-
Screening of Coexistence Between Sickle Cell Anaemia and G6PD Deficiency
NCT06615024 ·Status: NOT_YET_RECRUITING
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
NCT05153967 ·Status: RECRUITING